Skip to content

Clinical trials

Completed Phase 3 Neurotoxicity Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurotoxicity Syndromes Phase: Phase 3 Status: Completed Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20031
20041
20051
20062
20073
20083
20092
20101
20111
20151
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology10
Sanofi2
BioNumerik Pharmaceuticals, Inc.1
Gary Morrow1
Gynecologic Oncology Group1
M.D. Anderson Cancer Center1
Radiation Therapy Oncology Group1
SWOG Cancer Research Network1
Sun Yat-sen University1
Tianjin Medical University Cancer Institute and Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurotoxicity Syndromes21
Pain6
Colorectal Neoplasms5
Neoplasm Metastasis5
Peripheral Nervous System Diseases4
Breast Neoplasms3
Paresthesia3
Brain Neoplasms2
Colonic Neoplasms2
Leukemia2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.